Hemofarm AD Farmaceutsko-hemijska industrija Vrsac 2021 Sustainability Report
Company: Hemofarm AD Farmaceutsko-hemijska industrija Vrsac
Sector: Manufacturing
Country: Serbia
Year: 2021
Type: Sustainability Report
Pages: 83
The report presents Hemofarm's 2021 sustainability performance as the final part of a 2019–2021 triptych and reports in accordance with GRI Core across 117 indicators. It describes how the company maintained medicine supply through the pandemic and produced 287 million product packages during 2021. Hemofarm reported 2,931 employees, with women making up 54.42% of its workforce. The report also includes a limited-assurance review by Ernst & Young.
Indicators available in this report: